PL368321A1 - Zastosowanie cystationiny - Google Patents

Zastosowanie cystationiny

Info

Publication number
PL368321A1
PL368321A1 PL02368321A PL36832102A PL368321A1 PL 368321 A1 PL368321 A1 PL 368321A1 PL 02368321 A PL02368321 A PL 02368321A PL 36832102 A PL36832102 A PL 36832102A PL 368321 A1 PL368321 A1 PL 368321A1
Authority
PL
Poland
Prior art keywords
cystathionine
Prior art date
Application number
PL02368321A
Other languages
English (en)
Inventor
Paul-André Finot
Tuong Huynh-Ba
Jacques Vuichoud
Denis Breuille
Original Assignee
Societe Des Produits Nestle S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe Des Produits Nestle S.A. filed Critical Societe Des Produits Nestle S.A.
Publication of PL368321A1 publication Critical patent/PL368321A1/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06Anabolic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Dairy Products (AREA)
PL02368321A 2001-10-16 2002-10-08 Zastosowanie cystationiny PL368321A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01203902A EP1302115A1 (fr) 2001-10-16 2001-10-16 Utilisation de cystathionine

Publications (1)

Publication Number Publication Date
PL368321A1 true PL368321A1 (pl) 2005-03-21

Family

ID=8181067

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02368321A PL368321A1 (pl) 2001-10-16 2002-10-08 Zastosowanie cystationiny

Country Status (13)

Country Link
US (1) US20050064014A1 (pl)
EP (2) EP1302115A1 (pl)
JP (1) JP2005505599A (pl)
CN (1) CN1571637A (pl)
BR (1) BR0213299A (pl)
CA (1) CA2461758A1 (pl)
CO (1) CO5580729A2 (pl)
MX (1) MXPA04003499A (pl)
NO (1) NO20041968L (pl)
PL (1) PL368321A1 (pl)
RU (1) RU2004114844A (pl)
WO (1) WO2003032753A1 (pl)
ZA (1) ZA200403687B (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2886154B1 (fr) * 2005-05-27 2010-03-26 Cothera Composition pour retarder le developpement de la maladie d'alzheimer
WO2006134135A2 (en) * 2005-06-14 2006-12-21 Nestec S.A. Nutritional method for elderly people
EP2044851A1 (en) * 2007-09-26 2009-04-08 Nestec S.A. Prevention of allergy at weaning
KR101519654B1 (ko) * 2008-10-02 2015-05-18 (주)아모레퍼시픽 슬리밍용 조성물
FR2966040A1 (fr) * 2010-10-19 2012-04-20 Brigitte Gourlaouen Composition amincissante et/ou de prevention des processus inflammatoires
WO2012167092A2 (en) * 2011-06-03 2012-12-06 The Regents Of The University Of Colorado, A Body Corporate Uses of and methods of treatment with cystathionine
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
AU2013286876B2 (en) * 2012-07-03 2017-04-20 Jay Pravda Methods for treating, diagnosing and/or monitoring progression of oxo associated states
EP3145333B1 (en) 2014-05-19 2020-11-04 N.V. Nutricia Infant formula with optimised amino acid profiles
PL3145334T3 (pl) * 2014-05-19 2020-06-01 N.V. Nutricia Formulacje dojelitowe dla przedwcześnie urodzonych niemowląt zawierające zoptymalizowane poziomy przyjmowania fenyloalaniny
US20180279663A1 (en) * 2015-09-28 2018-10-04 Nestec S.A. Gender specific synthetic nutritional compositions and nutritional systems comprising them
JP6861708B2 (ja) * 2015-12-30 2021-04-21 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 除脂肪体重を測定するための方法
US11382885B2 (en) 2017-06-07 2022-07-12 The Regents Of The University Of California Compositions for treating fungal and bacterial biofilms and methods of using the same
US12226386B2 (en) 2018-12-03 2025-02-18 The Regents Of The University Of California Compositions and methods for treating biofilms

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419345A (en) * 1981-07-20 1983-12-06 Kinetic Systems, Inc. Sleep-inducing pharmaceutical composition and method
US4419435A (en) * 1982-05-21 1983-12-06 Eastman Kodak Company Photographic products and processes employing 6-heterocyclylazo-3-pyridinol nondiffusible cyan dye-releasing compounds and precursors thereof
JPH0621062B2 (ja) * 1988-11-10 1994-03-23 陶陶酒製造株式会社 肝障害抑制剤
FR2711529B1 (fr) * 1993-10-28 1996-07-05 Clintec Nutrition Cy Composition à base d'acides aminés destinée au traitement d'une infection ou d'une agression engendrant une réaction inflammatoire, chez les animaux et chez l'homme.
JP2727431B2 (ja) * 1994-10-04 1998-03-11 陶陶酒製造株式会社 生体内ラジカル消去剤
CA2217696A1 (en) * 1995-04-25 1996-10-31 Oridigm Corporation S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy
JPH107553A (ja) * 1996-03-21 1998-01-13 Toutoushiyu Seizo Kk 生体内ラジカル消去剤及び抗潰瘍剤
US6495170B1 (en) * 2000-08-16 2002-12-17 N. V. Nutricia Method of increasing the presence of glutathione in cells

Also Published As

Publication number Publication date
ZA200403687B (en) 2005-05-13
NO20041968L (no) 2004-05-11
JP2005505599A (ja) 2005-02-24
CN1571637A (zh) 2005-01-26
EP1437945A1 (fr) 2004-07-21
CO5580729A2 (es) 2005-11-30
MXPA04003499A (es) 2004-07-30
US20050064014A1 (en) 2005-03-24
EP1302115A1 (fr) 2003-04-16
CA2461758A1 (en) 2003-04-24
RU2004114844A (ru) 2005-10-27
WO2003032753A1 (fr) 2003-04-24
BR0213299A (pt) 2004-10-26

Similar Documents

Publication Publication Date Title
EP1387687A4 (en) NEW USE
GB0125088D0 (en) New use
PL368321A1 (pl) Zastosowanie cystationiny
GB0100762D0 (en) Novel use
GB0115181D0 (en) Novel use
HUP0500734A3 (en) Use of 2-alkoxyphenyl-substituted imidazotriazinones
GB0106031D0 (en) Use
GB0119920D0 (en) New use
GB0128122D0 (en) Therapeutic use
AU2002350507A1 (en) Use of cystathionine
HU0104370D0 (en) Honeyed schnaps of oerseg
GB0126000D0 (en) Use of 4ñ Phorbol
GB0112544D0 (en) Novel use and compounds
GB0103899D0 (en) Use
GB0108115D0 (en) Use
GB0126186D0 (en) Use
GB0103892D0 (en) Use
GB0102482D0 (en) Use
GB0115598D0 (en) New use
GB0117918D0 (en) New use
GB0217042D0 (en) New use
GB0112207D0 (en) New use
GB0114008D0 (en) New therapautic use
GB0119928D0 (en) New use
GB0130704D0 (en) New use

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)